Adamis Pharmaceuticals Corp
NASDAQ:ADMP
Adamis Pharmaceuticals Corp
Cash from Financing Activities
Adamis Pharmaceuticals Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adamis Pharmaceuticals Corp
NASDAQ:ADMP
|
Cash from Financing Activities
$285k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Financing Activities
-$21.4B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Financing Activities
$8.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Financing Activities
$26.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Financing Activities
-$5.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-7%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Financing Activities
$2.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Adamis Pharmaceuticals Corp's Cash from Financing Activities?
Cash from Financing Activities
285k
USD
Based on the financial report for Dec 31, 2022, Adamis Pharmaceuticals Corp's Cash from Financing Activities amounts to 285k USD.
What is Adamis Pharmaceuticals Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-99%
Over the last year, the Cash from Financing Activities growth was -99%.